|
NIDA Research Monograph, Number 163 [Printed in 1996]
Complete Monograph - Monograph163.pdf (1.2 MB)
Click on link to go to page
Table of Contents
Cocaine Addiction as a Neurological Disorder:
Implications for Treatment-----1
Maria Dorota Majewska
Brain Atropy and Chronic Cocaine Abuse:
Background and Work in Progress-----27
Frederick G. Langendorf, David C. Anderson, David E. Tupper,
David A. Rottenberg, and Irwin D. Weisman
Neurologic Complications of Cocaine-----43
Michael Daras
Psychomotor and Electroencephalographic
Sequelae of Cocaine Dependence-----66
Lance O. Bauer
Cocaine Effects on Dopamine and Opioid Peptide
Neural Systems: Implications for Human Cocaine Abuse-----94
Yasmin L. Hurd
The Neurotoxic Effects of Continuous Cocaine
and Amphetamine in Habenula: Implications for the Substrates of Psychosis-----117
Gaylord Ellison, Scott Irwin, Alan Keys, Kevin Noguchi, and Giri Sulur
PET Studies of Cerebral Glucose Metabolism:
Acute Effects of Cocaine and Long-Term Deficits in Brains of Drug Abusers-----146
Edythe D. London, June M. Stapelton, Robert L. Phillips, Steven J. Grant,
Victor L. Villemagne, Xiang Liu, and Rebeca Soria
Cardiotoxic Properties of Cocaine: Studies
with Positron Emission Tomography-----159
Nora D. Volkow, Joanna S. Fowler, and Yu-Shin Ding
Neuropsychological Abnormalities in Cocaine
Abusers: Possible Correlates in SPECT Neuroimaging-----175
Thomas R. Kosten, Robert Malison, and Elizabeth Wallace
Cocaine Withdrawal Alters Regulatory Elements
of Dopamine Neurons-----193
Nancy S. Pilotte and Lawrence G. Sharpe
EEG and Evoked Potentials Alterations
in Cocaine-Dependent Individuals-----203
Ronald I. Herning and Deborah E. King
Is Craving Mood Driven or Self-Propelled?
Sensitization and "Street" Stimulant Addiction-----224
Frank H. Gawin and M. Elena Khalsa-Denison
Methamphetamine and Methylenedioxymethamphetamine
Neurotoxicity: Possible Mechanisms of Cell Destruction-----251
Lewis S. Seiden and Karen E. Sabol
Stress, Glucocorticoids, and Mesencephalic
Dopaminergic Neurons: A Pathophysiological Chain Determining Vulnerability
to Psychostimulant Abuse-----277
Pier Vincenzo Piazza, Michela Marinelli, Françoise Rougé-Pont,
Véronique Deroche, Stefania Maccari, Hervé Simon, and Michel
Le Moal
Clinical and MRI Evaluation of Psychostimulant
Neurotoxicity-----300
George Bartzokis, Mace Beckson, and Walter Ling
Neurotoxic Versus Neuroprotective Actions
of Endogenous Opioid Peptides: Implications for Treatment of CNS Injury-----318
Alan I. Faden
|
|
|